Page 13 of 19

IM16.{13-14,16-17} | Diarrheal Disorder Treatment — SDL Guide (Part 3)

Self-Assessment: Integrating Diarrhoeal Treatment Decisions

The following scenarios require you to integrate rehydration assessment, antibiotic selection (or withholding), anti-parasitic drug selection with correct dosing, and surgical decision-making. Work through each before reading the analysis — this is the application level that the NMC KH competency requires.

Scenario A: A 25-year-old returns from a wedding where many guests fell ill with sudden-onset profuse watery diarrhoea. He has passed 6 litres of rice-water stools in 8 hours and is now in the emergency department unable to drink due to vomiting. BP 70/40 mmHg, HR 150/min, skin pinch recoils in >3 seconds, sunken eyes, altered sensorium. What is the immediate management, and when is antibiotic appropriate?

Analysis: Severe dehydration (Plan C) with hypovolaemic shock. Immediate: IV Ringer's Lactate 100 mL/kg — first 30 mL/kg in 30 minutes as rapid bolus to restore perfusion pressure; then 70 mL/kg over 2.5 hours. Monitor: radial pulse, BP, capillary refill, urine output. When patient is alert and tolerating oral intake, switch to WHO ORS. Antibiotic: once stable and tolerating oral intake, give doxycycline 300 mg single dose (or azithromycin if resistant cholera or pregnancy). Do NOT give antibiotic in shock — rehydration is the life-saving intervention, not the antibiotic.

Scenario B: A 38-year-old man is diagnosed with intestinal amoebiasis after stool microscopy showing E. histolytica trophozoites with erythrophagocytosis. He has no hepatic tenderness or fever. He is started on metronidazole 400 mg TDS for 10 days and his symptoms resolve completely. Two weeks later he returns requesting a repeat stool examination to confirm cure before stopping treatment. What is the CORRECT treatment status, and what further action is required?

Analysis: Metronidazole has been completed (correct). However, the luminal amoebicide has NOT been given. The patient still carries intraluminal cysts that metronidazole does not eradicate. The correct action: prescribe diloxanide furoate 500 mg TDS × 10 days immediately. Do not wait for a stool examination to confirm cyst presence — the stool examination result does not change the management (even if cysts are not detected on a single examination, cyst excretion is intermittent and the luminal agent is always required after tissue treatment for amoebiasis). Explain: this second drug prevents relapse and stops transmission to household contacts.

Scenario C: A 55-year-old man with 10-year UC (pancolitis) has been on mesalamine maintenance and has had three corticosteroid courses in the past 18 months. His most recent colonoscopy showed high-grade dysplasia in a flat lesion in the sigmoid colon. He is otherwise well and has no acute symptoms. What is the recommended management?

Analysis: High-grade dysplasia in UC is an indication for elective colectomy — it is a precursor to colorectal carcinoma, and in the context of long-standing pancolitis, the entire colon is at risk. This is not urgent (no acute emergency), but should be planned promptly with surgical referral. The procedure of choice: total proctocolectomy with ileo-anal pouch anastomosis (J-pouch). The three corticosteroid courses in 18 months additionally indicate steroid dependence — another indication for surgical consideration even before dysplasia appeared, though dysplasia takes clinical priority now. Pre-operative preparation: stop/bridge immunosuppressants (per surgical team guidance), nutritional optimisation, patient education about ileostomy (temporary, while the pouch heals).

CLINICAL PEARL

The most important drug safety rule in acute diarrhoeal treatment is that antimotility agents (loperamide, codeine) are absolutely contraindicated in dysentery and invasive diarrhoea (fever, bloody/mucoid stools). Slowing intestinal motility increases mucosal contact time with invasive organisms and Shiga/cytotoxins, and significantly increases the risk of toxic megacolon, bacteraemia, and prolonged illness. Students and clinicians in India frequently encounter patients who have taken loperamide (available OTC) for their dysentery before presentation — always document this and monitor for signs of colonic dilatation. Loperamide is appropriate only in functional diarrhoea (IBS-D) and in acute watery diarrhoea without fever or blood — it is never safe when mucosal invasion is possible.

A second pearl for the amoebiasis protocol: metronidazole + diloxanide furoate is a non-negotiable two-drug sequence. Giving metronidazole alone for intestinal amoebiasis is an incomplete treatment that leaves luminal cysts behind. Many practitioners and even some printed drug charts in India list only metronidazole for amoebiasis — this is incorrect. The complete treatment is always: tissue agent first (metronidazole or tinidazole), then luminal agent (diloxanide furoate or paromomycin) immediately after, without a gap.

Interactive practice: Multiple Choice

Interactive practice: True / False